{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:00:10Z","timestamp":1794718810042,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["1-S10-OD032249-01"],"award-info":[{"award-number":["1-S10-OD032249-01"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL151924"],"award-info":[{"award-number":["HL151924"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM135399"],"award-info":[{"award-number":["GM135399"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["NIH-T32"],"award-info":[{"award-number":["NIH-T32"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["24CDA1275780"],"award-info":[{"award-number":["24CDA1275780"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xcrm.2025.102125","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T11:50:43Z","timestamp":1746618643000},"page":"102125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling"],"prefix":"10.1016","volume":"6","author":[{"given":"Sobuj","family":"Mia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Siokatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafailia","family":"Sidiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Fragkiadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia","family":"Markopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud I.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajika","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erjola","family":"Rapushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipayan","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Makarewich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Molkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marketou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-834X","authenticated-orcid":false,"given":"Konstantinos","family":"Drosatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102125_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-71-1-89","article-title":"Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study","volume":"71","author":"Kannel","year":"1969","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061799","article-title":"Mitochondrial Energetics and Ca2(+)-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy","volume":"9","author":"Lombardi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping hypertrophy: eschew obfuscation","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPAR\u03b1 and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPAR\u03b1-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib7","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine","volume":"582","author":"Izumiya","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2025.102125_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/mol.108.044826","article-title":"Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor \u03b3 and altered metabolic states","volume":"74","author":"Muise","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102125_bib9","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","article-title":"Thermogenic activation induces FGF21 expression and release in brown adipose tissue","volume":"286","author":"Hondares","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102125_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148252","article-title":"Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas","volume":"11","author":"Singhal","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102125_bib11","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bbadis.2019.04.010","article-title":"Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21","volume":"1865","author":"Pol","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.xcrm.2025.102125_bib12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102125_bib13","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2025.102125_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102125_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2119\/molmed.2011.00075","article-title":"Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21","volume":"17","author":"Chartoumpekis","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2025.102125_bib20","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib21","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102125_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008910","article-title":"FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure","volume":"15","author":"Sommakia","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.xcrm.2025.102125_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep33953","article-title":"Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction","volume":"6","author":"Chou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102125_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/jhh.2012.52","article-title":"Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults","volume":"27","author":"Semba","year":"2013","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.xcrm.2025.102125_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000509239","article-title":"Fibroblast growth factor 21 correlates with the prognosis of dilated cardiomyopathy","volume":"146","author":"Gu","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.xcrm.2025.102125_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102125_bib27","first-page":"738","article-title":"Epicardial, paracardial, and perivascular fat quantity, gene expressions, and serum cytokines in patients with coronary artery disease and diabetes","volume":"129","author":"Haberka","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48356-1","article-title":"Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts","volume":"9","author":"Sunaga","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102125_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cyto.2015.02.019","article-title":"Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients","volume":"73","author":"Han","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2025.102125_bib30","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1038\/s41598-022-11033-x","article-title":"FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes","volume":"12","author":"Yanucil","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102125_bib31","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2\u2013Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102125_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/cvu263","article-title":"Fibroblast growth factor 21 protects the heart from oxidative stress","volume":"106","author":"Planavila","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib33","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102125_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.xcrm.2025.102125_bib35","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.xcrm.2025.102125_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2016.11.008","article-title":"A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism","volume":"6","author":"Fisher","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib37","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2025.102125_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2025.102125_bib39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.xcrm.2025.102125_bib40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2025.102125_bib41","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2025.102125_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib43","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib44","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2025.102125_bib45","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.febslet.2009.09.012","article-title":"Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob\/ob mice","volume":"583","author":"Li","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2025.102125_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ijo.2013.79","article-title":"Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta)","volume":"38","author":"Nygaard","year":"2014","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.xcrm.2025.102125_bib47","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1194\/jlr.M044784","article-title":"Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis","volume":"55","author":"Brahma","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib48","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/dom.13023","article-title":"Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates","volume":"19","author":"Kim","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade4110","article-title":"An IL-6\/STAT3\/MR\/FGF21 axis mediates heart-liver cross-talk after myocardial infarction","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102125_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ijmm.2024.5378","article-title":"Ultrasound-targeted microbubble destruction technology delivering \u03b2-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction","volume":"53","author":"Yue","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cmet.2020.08.018","article-title":"A2A receptor activation attenuates hypertensive cardiac remodeling via promoting brown adipose tissue-derived FGF21","volume":"32","author":"Ruan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/path.5226","article-title":"Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease","volume":"248","author":"Ferrer-Curriu","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.xcrm.2025.102125_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","article-title":"FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism","volume":"459","author":"Joki","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102125_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087102","article-title":"Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102125_bib55","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.102125_bib56","first-page":"105","article-title":"Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young\u2014FGF-21 Highly Associated with Overt Disease","volume":"11","author":"\u00d6sterberg","year":"2024","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.xcrm.2025.102125_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacbts.2015.12.001","article-title":"The Role of the L-Type Ca(2+) Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic Cardiomyopathy","volume":"1","author":"Viola","year":"2016","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.xcrm.2025.102125_bib58","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/cvr\/cvx088","article-title":"Fgf21 is required for cardiac remodeling in pregnancy","volume":"113","author":"Redondo-Angulo","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.11.5.416","article-title":"Effects of moderate hypertension on cardiac function and metabolism in the rabbit","volume":"11","author":"Taegtmeyer","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.xcrm.2025.102125_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128722","article-title":"Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart","volume":"4","author":"Khalil","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102125_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"Takeda","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102125_bib62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/beta-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s44161-022-00116-7","article-title":"Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction","volume":"1","author":"Ngwenyama","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib64","doi-asserted-by":"crossref","first-page":"14558","DOI":"10.1073\/pnas.95.24.14558","article-title":"Rat heart: a site of oxytocin production and action","volume":"95","author":"Jankowski","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102125_bib65","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3389\/fpsyg.2020.02139","article-title":"The Role of Oxytocin in Cardiovascular Protection","volume":"11","author":"Jankowski","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.xcrm.2025.102125_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijcard.2014.04.174","article-title":"Anti-hypertrophic effects of oxytocin in rat ventricular myocytes","volume":"175","author":"Menaouar","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib67","doi-asserted-by":"crossref","first-page":"H265","DOI":"10.1152\/ajpheart.00487.2009","article-title":"Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats","volume":"299","author":"Jankowski","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00395-023-01013-1","article-title":"Outcomes of hypothalamic oxytocin neuron-driven cardioprotection after acute myocardial infarction","volume":"118","author":"Schunke","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mce.2015.04.028","article-title":"Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion","volume":"412","author":"Gonzalez-Reyes","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.xcrm.2025.102125_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00395-009-0076-5","article-title":"Anti-inflammatory effect of oxytocin in rat myocardial infarction","volume":"105","author":"Jankowski","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib71","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1073\/pnas.92.17.7902","article-title":"Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat","volume":"92","author":"Haanwinckel","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102125_bib72","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.94.21.11704","article-title":"Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart","volume":"94","author":"Gutkowska","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102125_bib73","first-page":"1267","article-title":"Oxytocin receptor binding in rat and human heart","volume":"15","author":"Cicutti","year":"1999","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib74","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1038\/s41467-018-07033-z","article-title":"Neuronal SIRT1 regulates macronutrient-based diet selection through FGF21 and oxytocin signalling in mice","volume":"9","author":"Matsui","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102125_bib75","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102125_bib76","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib77","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065763","article-title":"LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys","volume":"8","author":"Adams","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102125_bib79","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/en.2016-1917","article-title":"A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward beta-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys","volume":"158","author":"Stanislaus","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib80","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/en.2013-1191","article-title":"Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102125_bib81","first-page":"4750","article-title":"An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function","volume":"8","author":"Lee","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10928-016-9481-1","article-title":"PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates","volume":"43","author":"Thompson","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.xcrm.2025.102125_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004690","article-title":"Treating diabetes and obesity with an FGF21-mimetic antibody activating the betaKlotho\/FGFR1c receptor complex","volume":"4","author":"Foltz","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib84","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1074\/jbc.RA118.004343","article-title":"Agonistic beta-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions","volume":"293","author":"Min","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102125_bib85","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.molmet.2017.09.003","article-title":"FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1\/betaKlotho complex in non-adipocytes","volume":"6","author":"Chen","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2025.102125_bib86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.xcrm.2025.102125_bib87","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41591-023-02427-z","article-title":"The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial","volume":"29","author":"Bhatt","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102125_bib88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib89","doi-asserted-by":"crossref","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","article-title":"Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools","volume":"44","author":"Sud","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib90","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2025.102125_bib91","first-page":"577","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.xcrm.2025.102125_bib92","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2025.102125_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100511","article-title":"Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH","volume":"2","author":"Daemen","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2025.102125_bib94","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102125_bib95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102125_bib96","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102125_bib97","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102125_bib98","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.xcrm.2025.102125_bib99","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS A J. Integr. Biol."},{"key":"10.1016\/j.xcrm.2025.102125_bib100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ab.2007.10.002","article-title":"High-throughput tissue extraction protocol for NMR-and MS-based metabolomics","volume":"372","author":"Wu","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.xcrm.2025.102125_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/71a874d8-881f-4716-83ce-7af9fffb5462","article-title":"Evaluation of Pacific white shrimp (Litopenaeus vannamei) health during a superintensive aquaculture growout using NMR-based metabolomics","volume":"8","author":"Schock","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102125_bib102","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s11306-015-0789-4","article-title":"Application of NMR-based metabolomics for environmental assessment in the Great Lakes using zebra mussel (Dreissena polymorpha)","volume":"11","author":"Watanabe","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.xcrm.2025.102125_bib103","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jcmgh.2022.12.016","article-title":"Enteroendocrine cells protect the stem cell niche by regulating crypt metabolism in response to nutrients","volume":"15","author":"McCauley","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2025.102125_bib104","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/cpbi.86","article-title":"Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis","volume":"68","author":"Chong","year":"2019","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102125_bib105","doi-asserted-by":"crossref","first-page":"D527","DOI":"10.1093\/nar\/gkl838","article-title":"LMSD: LIPID MAPS structure database","volume":"35","author":"Sud","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102125_bib106","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125001983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125001983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:19:16Z","timestamp":1778919556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125001983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666379125001983"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102125","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102125"}}